- Home
- PHGE vs GLXG Comparison
PHGE vs GLXG Comparison
Compare PHGE & GLXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHGE
- GLXG
- Stock Information
- Founded
- PHGE 2015
- GLXG 2013
- Country
- PHGE Israel
- GLXG Hong Kong
- Employees
- PHGE N/A
- GLXG N/A
- Industry
- PHGE Biotechnology: Pharmaceutical Preparations
- GLXG
- Sector
- PHGE Health Care
- GLXG
- Exchange
- PHGE Nasdaq
- GLXG NYSE
- Market Cap
- PHGE 11.0M
- GLXG 8.8M
- IPO Year
- PHGE N/A
- GLXG 2024
- Fundamental
- Price
- PHGE $0.44
- GLXG $0.55
- Analyst Decision
- PHGE Strong Buy
- GLXG
- Analyst Count
- PHGE 1
- GLXG 0
- Target Price
- PHGE $15.00
- GLXG N/A
- AVG Volume (30 Days)
- PHGE 284.6K
- GLXG 174.7K
- Earning Date
- PHGE 08-13-2025
- GLXG 08-16-2025
- Dividend Yield
- PHGE N/A
- GLXG N/A
- EPS Growth
- PHGE N/A
- GLXG N/A
- EPS
- PHGE N/A
- GLXG N/A
- Revenue
- PHGE N/A
- GLXG $3,711,233.00
- Revenue This Year
- PHGE N/A
- GLXG N/A
- Revenue Next Year
- PHGE N/A
- GLXG N/A
- P/E Ratio
- PHGE N/A
- GLXG N/A
- Revenue Growth
- PHGE N/A
- GLXG N/A
- 52 Week Low
- PHGE $0.34
- GLXG $0.39
- 52 Week High
- PHGE $3.86
- GLXG $16.93
- Technical
- Relative Strength Index (RSI)
- PHGE 43.34
- GLXG N/A
- Support Level
- PHGE $0.43
- GLXG N/A
- Resistance Level
- PHGE $0.48
- GLXG N/A
- Average True Range (ATR)
- PHGE 0.05
- GLXG 0.00
- MACD
- PHGE 0.00
- GLXG 0.00
- Stochastic Oscillator
- PHGE 58.82
- GLXG 0.00
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).
About GLXG GALAXY PAYROLL GROUP LTD
Galaxy Payroll Group Ltd provides payroll outsourcing, employment, consultancy, and market research services based in Hong Kong. Its client base includes retail, trading, industrial, IT, financial, and professional services industries. Geographically, the company derives maximum revenue from its clients in the People's Republic of China and the rest from Hong Kong, Macau, Taiwan, Japan, Thailand, Singapore, and other countries.